Araştırma Makalesi

The adherence of parents regarding epinephrine auto-injector use in anaphylaxis management: a real-life study

Cilt: 48 Sayı: 1 31 Mart 2023
PDF İndir
TR EN

The adherence of parents regarding epinephrine auto-injector use in anaphylaxis management: a real-life study

Abstract

Purpose: The purpose of this study was to identify unmet needs in the management of anaphylaxis by assessing the practical skills of the parent(s) regarding the use of epinephrine auto-injectors (EAIs) and determining the factors influencing them. Materials and Methods: The study included 114 primary caregivers of children prescribed an EAI with an anaphylaxis risk. A structured mini-interview with a practice test using a trainer device was performed. Results: Epinephrine was described as a life-saving and first-line treatment for anaphylaxis by 93 parents (81.6%). However, only 53 parents (46.5%) stated that they carry an EIA device with them regularly in their daily lives. 38 children (33.3%) had relapsing episodes, but among those experiencing anaphylaxis, only 6 parents (20%) used EAI despite carrying. According to respondents, the main factor avoiding AEI's regular carriage was a lack of belief in necessity (18, 29.5%). Among participants, only 13 (11.4%) of the parents were able to administer EAI correctly in all 5 steps. An inverse relationship between the ability to use the device and the time elapsed since the last visit s was found. Conclusion: Low adherence levels among parents highlighted the urgent need to improve this situation. Interventions including regular EAI training and psychological support should be provided among parents, but may not guarantee to maintain acquired adherence to EAIs in real life.

Keywords

anaphylaxis , children , parents , epinephrine auto-injector , adherence

Kaynakça

  1. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13:100472.
  2. Prince BT, Mikhail I, Stukus DR. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy. 2018;11:143-151.
  3. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Kayli A, Lange L, Spindler T et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137:1128-1137.
  4. Serbes M, Sasihuseyinoglu AS, Ozcan D, Ufuk Altıntas D. Clinical features of anaphylaxis in children. Allergy Asthma Proc. 2022;43(1):50-56.
  5. Esenboga S, Ocak M, Cetinkaya PG, Sahiner UM, Soyer O, Buyuktiryaki B et al. Physicians prescribe adrenaline autoinjectors, do parents use them when needed? Allergol Immunopathol (Madr). 2020;48:3-7.
  6. Topal E, Bakirtas A, Yilmaz O, Ertoy IH, Arga M, Demirsoy MS et al. A real-life study on acquired skills from using an adrenaline autoinjector. Int Arch Allergy Immunol. 2013;160:301-6.
  7. Ito K, Ono M, Kando N, Matsui T, Nakagawa T, Sugiura S et al. Surveillance of the use of adrenaline auto-injectors in Japanese children. Allergol Int. 2018;67:195-200.
  8. Feuille E, Lawrence C, Volel C, Sicherer SH, Wang J. Time trends in food allergy diagnoses, epinephrine orders, and epinephrine administrations in New York City Schools. J Pediatr. 2017;190:93-99.
  9. Kahveci M, Akarsu A, Koken G, Sahiner UM, Soyer O, Sekerel BE. Food-induced anaphylaxis in infants, as compared to toddlers and preschool children in Turkey. Pediatr Allergy Immunol. 2020;31:954-961.
  10. Ratanaprug C, Srisuwatchari W, Jirapongsananuruk O, Visitsunthorn N, Pacharn P. Carrying rates of epinephrine devices in children with food-induced anaphylaxis. Asia Pac Allergy. 2019;9:e12.

Kaynak Göster

MLA
Serbes, Mahir, vd. “The adherence of parents regarding epinephrine auto-injector use in anaphylaxis management: a real-life study”. Cukurova Medical Journal, c. 48, sy 1, Mart 2023, ss. 234-42, doi:10.17826/cumj.1246648.